High dose steroid treatment could limit the extent of acute inflammation and the demyelination process. nontreatment groups was related at baseline and 3 months (P 0.1). Treatment offered better VA at 3 months (0.1 0.2 versus 0.3 0.2 LogMAR,P= 0.04).Summary. Generalized RNFL thinning occurred at 3 months after a first episode of acute optic neuritis most significantly in the temporal quadrant and average thickness. Visual improvement with treatment was self-employed of RNFL thickness. == 1. Intro == Optic neuritis is definitely a demyelinating swelling of the optic nerve characterised by a sudden onset of vision Trimethobenzamide hydrochloride loss and dyschromatopsia associated with ocular pain [1]. Postinflammatory changes include axonal loss and optic nerve atrophy [2]. Optical coherence tomography (OCT) is definitely a noncontact imaging device used in ophthalmology to provide high resolution cross-sectional images and quantification of the ocular constructions, namely, the macula, optic nerve head, and retinal nerve fibre coating (RNFL). In recent years, neuroophthalmologists recommended use of OCT for objective morphological assessment and quantification of optic nerve head and peripapillary RNFL thickness [3]. Therefore, structural axonal loss in the optic nerve can be quantified by measuring the peripapillary RNFL thickness using OCT [4]. Measuring the RNFL thickness after an acute episode of optic neuritis provides a structural assessment of the optic nerve, enables prognostic evaluations, and may also help to differentiate between neuromyelitis optica (NMO) and multiple sclerosis (MS) [5,6]. The Trimethobenzamide hydrochloride aim of this study was to assess the changes in RNFL after a first assault of optic neuritis and to investigate the effect of treatment on axonal loss. == 2. Individuals and Methods == The study was authorized by the Institutional Review Table of the Hospital Expert of Hong Kong and educated consent was acquired prior to commencement of the study. The study was carried out in accordance with the Declaration of Helsinki. This is a prospective cohort study carried out by Caritas Medical Centre, Hong Kong between October 2010 and December 2012. Consecutive, consenting adults, 1880 years of age, diagnosed with a first episode of isolated unilateral acute (<8 days Rabbit polyclonal to ZFAND2B of symptoms) optic neuritis were recruited and adopted up for at least 3 months. The analysis of optic neuritis was made based on a compatible history including ocular pain; clinical exam demonstrating impairment of optic nerve function including dyschromatopsia, visual acuity (VA) impairment, optic disc swelling, or relative afferent papillary defect; andthe absence of any space occupying lesion on a computed tomography Trimethobenzamide hydrochloride scan of the brain and orbit. All subjects underwent neuroophthalmic exam by an ophthalmologist (SKY) and a neurologist (PKL). All subjects underwent imaging for RNFL thickness via a spectral-domain OCT (Heidelberg Executive, CA, USA). Contrast magnetic resonance image (MRI) scan of the brain and orbit and blood taking for autoimmune markers and aquaporin-4 antibody were Trimethobenzamide hydrochloride consequently performed to rule out other causes of optic neuritis. Subjects with known or confirmed analysis of MS, NMO, autoimmune disease, additional optic neuropathies, and glaucoma were excluded. Subjects with a high visual demand requiring a hastened visual recovery, were given a systemic steroid treatment (intravenous methyl-prednisolone 250 mg every 6 hours Trimethobenzamide hydrochloride for 3 days, followed by oral prednisone 1 mg/kg/day time for 11 days) as per the Optic Neuritis Treatment Trial (ONTT) protocol [7] after explanation of the risks and benefits of treatment (treatment group). The nontreatment group did not receive any active medical treatment. Best corrected Snellen VA was measured at baseline and 3 months and converted to LogMAR for statistical analysis. == 2.1. Measurement of the Peripapillary RNFL.